Related references
Note: Only part of the references are listed.A new treatment strategy for airway obstruction induced by a giant benign goiter: A case report
Qinwei Zhu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2023)
Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study
Julia Degering et al.
RESPIRATORY RESEARCH (2023)
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
Marc Humbert et al.
EUROPEAN HEART JOURNAL (2022)
Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease
Keiichi Torimoto et al.
SCIENTIFIC REPORTS (2022)
Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement
Laura C. Price et al.
BRITISH JOURNAL OF ANAESTHESIA (2021)
Risk stratification and medical therapy of pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension
Yuichi Tamura et al.
CIRCULATION JOURNAL (2018)
Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension
Mari Satoh et al.
ENDOCRINE JOURNAL (2017)
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
Douglas S. Ross et al.
THYROID (2016)
Pulmonary hypertension and its management in patients undergoing non-cardiac surgery
S. A. Pilkington et al.
ANAESTHESIA (2015)
American Thyroid Association Statement on Optimal Surgical Management of Goiter
Amy Y. Chen et al.
THYROID (2014)
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
Raymond L. Benza et al.
CHEST (2012)
PGI2 as a regulator of CD4+subset differentiation and function
Madison G. Boswell et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
Marked Hemodynamic Improvements by High-Dose Epoprostenol Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
Satoshi Akagi et al.
CIRCULATION JOURNAL (2010)
EFFECT OF EPOPROSTENOL ON THE THYROID GLAND: ENLARGEMENT AND SECRETION OF THYROID HORMONE
Chhavi Chadha et al.
ENDOCRINE PRACTICE (2009)
Management of life-threatening airway obstruction caused by benign thyroid disease
A. L. Kadhim et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2006)
Cardiovascular abnormalities in hyperthyroidism:: A prospective Doppler echocardiographic study
J Mercé et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Surgical management of multinodular goiter with compression symptoms
A Rios et al.
ARCHIVES OF SURGERY (2005)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery
LH Clapp et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Share Paper
